A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Bipolar I disorders; Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2010 Actual end date changed from Mar 2010 to Dec 2010 as reported by ClinicalTrials.gov.
    • 14 Dec 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Primary endpoint 'Pittsburgh-Sleep-Quality-Index' has not been met
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top